Primary Aldosteronism
Endocrine SocietyPublished: July 14, 2025
- Background
- Diagnosis
- Tables
- Prevalence of Primary Aldosteronism in Different Subgroups
- Evidence for the Recommendation of Primary Aldosteronism Screening
- PA Screening: ARR Cut Points According to Aldosterone and Renin Assay and Unit Measurements
- Medications That Interfere With PA Screening and Their Effects on Aldosterone and Renin
- Managing Interfering Antihypertensive Medications During PA Screening and Interpretation of Aldosterone, Renin and ARR
- Description of the Most Commonly Used Aldosterone-Suppression Tests
- Key Indices and Cutoffs for Adrenal Vein Sampling Interpretation
- Comparisons of MRA and ENaC Inhibitors
- Figures and Algorithms
- How to Screen for PA in Individuals With Hypertension
- Management of Adults With Hypertension in whom PA is Likely Based on Aldosterone, Renin and ARR
- Initiating and Following MRA Therapy
Also Found In
You rely on Guideline Central for transparency
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.